230 related articles for article (PubMed ID: 28599657)
1. Comparison of methods for calculating the health costs of endocrine disrupters: a case study on triclosan.
Prichystalova R; Fini JB; Trasande L; Bellanger M; Demeneix B; Maxim L
Environ Health; 2017 Jun; 16(1):55. PubMed ID: 28599657
[TBL] [Abstract][Full Text] [Related]
2. Calculation of the disease burden associated with environmental chemical exposures: application of toxicological information in health economic estimation.
Grandjean P; Bellanger M
Environ Health; 2017 Dec; 16(1):123. PubMed ID: 29202828
[TBL] [Abstract][Full Text] [Related]
3. Estimating burden and disease costs of exposure to endocrine-disrupting chemicals in the European union.
Trasande L; Zoeller RT; Hass U; Kortenkamp A; Grandjean P; Myers JP; DiGangi J; Bellanger M; Hauser R; Legler J; Skakkebaek NE; Heindel JJ
J Clin Endocrinol Metab; 2015 Apr; 100(4):1245-55. PubMed ID: 25742516
[TBL] [Abstract][Full Text] [Related]
4. Male reproductive disorders, diseases, and costs of exposure to endocrine-disrupting chemicals in the European Union.
Hauser R; Skakkebaek NE; Hass U; Toppari J; Juul A; Andersson AM; Kortenkamp A; Heindel JJ; Trasande L
J Clin Endocrinol Metab; 2015 Apr; 100(4):1267-77. PubMed ID: 25742517
[TBL] [Abstract][Full Text] [Related]
5. Female Reproductive Disorders, Diseases, and Costs of Exposure to Endocrine Disrupting Chemicals in the European Union.
Hunt PA; Sathyanarayana S; Fowler PA; Trasande L
J Clin Endocrinol Metab; 2016 Apr; 101(4):1562-70. PubMed ID: 27003299
[TBL] [Abstract][Full Text] [Related]
6. Neurobehavioral deficits, diseases, and associated costs of exposure to endocrine-disrupting chemicals in the European Union.
Bellanger M; Demeneix B; Grandjean P; Zoeller RT; Trasande L
J Clin Endocrinol Metab; 2015 Apr; 100(4):1256-66. PubMed ID: 25742515
[TBL] [Abstract][Full Text] [Related]
7. Exposure to endocrine-disrupting chemicals in the USA: a population-based disease burden and cost analysis.
Attina TM; Hauser R; Sathyanarayana S; Hunt PA; Bourguignon JP; Myers JP; DiGangi J; Zoeller RT; Trasande L
Lancet Diabetes Endocrinol; 2016 Dec; 4(12):996-1003. PubMed ID: 27765541
[TBL] [Abstract][Full Text] [Related]
8. Burden of disease and costs of exposure to endocrine disrupting chemicals in the European Union: an updated analysis.
Trasande L; Zoeller RT; Hass U; Kortenkamp A; Grandjean P; Myers JP; DiGangi J; Hunt PM; Rudel R; Sathyanarayana S; Bellanger M; Hauser R; Legler J; Skakkebaek NE; Heindel JJ
Andrology; 2016 Jul; 4(4):565-72. PubMed ID: 27003928
[TBL] [Abstract][Full Text] [Related]
9. Obesity, diabetes, and associated costs of exposure to endocrine-disrupting chemicals in the European Union.
Legler J; Fletcher T; Govarts E; Porta M; Blumberg B; Heindel JJ; Trasande L
J Clin Endocrinol Metab; 2015 Apr; 100(4):1278-88. PubMed ID: 25742518
[TBL] [Abstract][Full Text] [Related]
10. Population attributable risks and costs of diabetogenic chemical exposures in the elderly.
Trasande L; Lampa E; Lind L; Lind PM
J Epidemiol Community Health; 2017 Feb; 71(2):111-114. PubMed ID: 27789757
[TBL] [Abstract][Full Text] [Related]
11. Effect thresholds and 'adequate control' of risks: The fatal flaws in the EU council's position on authorisation within REACH.
Santillo D; Johnston P
Environ Sci Pollut Res Int; 2006 Oct; 13(6):425-31. PubMed ID: 17120834
[TBL] [Abstract][Full Text] [Related]
12. Reproductive endocrine-disrupting effects of triclosan: Population exposure, present evidence and potential mechanisms.
Wang CF; Tian Y
Environ Pollut; 2015 Nov; 206():195-201. PubMed ID: 26184583
[TBL] [Abstract][Full Text] [Related]
13. Implications of research on endocrine disruption for the environmental risk assessment, regulation and monitoring of chemicals in the European Union.
Matthiessen P; Johnson I
Environ Pollut; 2007 Mar; 146(1):9-18. PubMed ID: 16996184
[TBL] [Abstract][Full Text] [Related]
14. Hypothesis-driven weight-of-evidence analysis of endocrine disruption potential: a case study with triclosan.
Mihaich E; Capdevielle M; Urbach-Ross D; Slezak B
Crit Rev Toxicol; 2017 Apr; 47(4):263-285. PubMed ID: 28128023
[TBL] [Abstract][Full Text] [Related]
15. Socio-economic analysis in REACH restriction dossiers for chemicals management: A critical review.
Gabbert S; Hilber I
Ambio; 2020 Aug; 49(8):1394-1411. PubMed ID: 31808106
[TBL] [Abstract][Full Text] [Related]
16. [Environment and health in Gela (Sicily): present knowledge and prospects for future studies].
Musmeci L; Bianchi F; Carere M; Cori L
Epidemiol Prev; 2009; 33(3 Suppl 1):7-12. PubMed ID: 19776462
[TBL] [Abstract][Full Text] [Related]
17. Consumer products as sources of chemical exposures to children: case study of triclosan.
Ginsberg GL; Balk SJ
Curr Opin Pediatr; 2016 Apr; 28(2):235-42. PubMed ID: 26867165
[TBL] [Abstract][Full Text] [Related]
18. Disease burden attributable to endocrine-disrupting chemicals exposure in China: A case study of phthalates.
Cao Y; Li L; Shen K; Liu J
Sci Total Environ; 2019 Apr; 662():615-621. PubMed ID: 30699382
[TBL] [Abstract][Full Text] [Related]
19. ECETOC Florence workshop on risk assessment of endocrine substances, including the potency concept.
Fegert I
Toxicol Lett; 2013 Dec; 223(3):310-4. PubMed ID: 23558296
[TBL] [Abstract][Full Text] [Related]
20. Identification, assessment and management of "endocrine disruptors" in wildlife in the EU substance legislation--discussion paper from the German Federal Environment Agency (UBA).
Frische T; Bachmann J; Frein D; Juffernholz T; Kehrer A; Klein A; Maack G; Stock F; Stolzenberg HC; Thierbach C; Walter-Rohde S
Toxicol Lett; 2013 Dec; 223(3):306-9. PubMed ID: 23500481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
